Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Trial of Non-ablative Cryosurgical Freezing and Multiplex Immunotherapy in Patients With Metastatic Solid Cancer

NCT04739618 is registered in ClinicalTrials.gov with ImmunSYS, LLC as lead sponsor.

NCT NCT04739618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04739618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Trial of Non-ablative Cryosurgical Freezing and Multiplex Immunotherapy in Patients With Metastatic Solid Cancer
Lead sponsor
ImmunSYS, LLC
Phase
Phase 2
Overall status
Unknown status
Start date
March 4, 2021
Completion date
December 31, 2024
Enrollment
32 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer